Siegfried to introduce functional organization
Effective March 1, 2010, the Siegfried Group will introduce a functional organization to replace its current two-division structure. The new structure is a result of strategic adjustments approved in the summer of 2009. Siegfried will increasingly market its two core capabilities, namely the development and production of active pharmaceutical ingredients and finished dosage forms, as a single package.
CEO Rudolf Hanko: “Siegfried is one of the rare suppliers of the pharmaceutical industry that is capable of providing both the chemical synthesis of active pharmaceutical ingredients and production of finished dosage forms. Our new organizational structure will make allowance for this fact. In the future we will be able to convey this attractive offer in a much more effective way.”
The future Executive Committee of Siegfried will consist of seven members: Rudolf Hanko, CEO, Michael Hüsler, CFO, and Hanspeter Brun, Head of HR, will continue in the same function. Marianne Späne, formerly head of the Siegfried Generics division, will be responsible for Business Development and Sales. Hubert Stückler, formerly head of the Siegfried Actives division, will be responsible for the world-wide technical operations. Former Chief Communications Officer, Peter Gehler, will head the Corporate Center, which includes communication, the legal department, facility management and the Chairman’s Office. In addition to his duties as CEO, Rudolf Hanko will assume responsibility for Research & Development on an interim basis until the position of Head of R & D is filled.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
